← Back to Search

Nutritional Supplement

Nutritional Supplement for Gastrointestinal Issues

N/A
Recruiting
Research Sponsored by Athletic Greens International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged between 18 and 60 years
Not currently taking and not planning on introducing any product, supplement or medication aimed at gut health or nutritional gaps during the study period
Must not have
Currently taking any opioid medications such as oxycodone, hydrocodone, codeine, morphine, or kratom
Celiac disease/gluten intolerance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Summary

This trial is testing a new dietary supplement on 40 adults who sometimes have stomach problems. They want to see if the supplement can help with nutrient deficiencies, stomach issues, and the balance of bacteria in

Who is the study for?
This trial is for adult men and women who sometimes have gastrointestinal issues. It's designed to see if a new dietary supplement can help with nutrient deficiencies and gut health.
What is being tested?
The study tests a nutritional supplement called AG1 against a placebo, which has no active ingredients. Participants won't know which one they're taking. The goal is to see if AG1 improves GI symptoms and the gut microbiome.
What are the potential side effects?
Possible side effects of the nutritional supplement may include digestive discomfort or allergic reactions, but specific side effects will be monitored throughout the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 60 years old.
Select...
I am not using and do not plan to use any gut health or nutritional supplements during the study.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently taking opioid medications like oxycodone or morphine.
Select...
I have celiac disease or am gluten intolerant.
Select...
I have diabetes or another hormone-related condition.
Select...
I have had hyperparathyroidism or an untreated thyroid condition.
Select...
I am currently taking medication for IBS.
Select...
I have lost 10% or more of my body weight in the last 3 months.
Select...
I have had cancer in my digestive system before.
Select...
I haven't had cancer in the last 5 years, except for non-melanoma skin cancer.
Select...
I have had surgery to reroute my intestines.
Select...
I am not taking supplements with ingredients similar to the test product.
Select...
I have no recent serious heart, liver, or kidney problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Digestive Measures
GI Symptoms
Gut Microbiome
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AG1 - Nutritional SupplementExperimental Treatment1 Intervention
A foundational nutritional supplement consisting of vitamins, minerals, probiotics, prebiotics, and whole food ingredients
Group II: PlaceboPlacebo Group1 Intervention
Maltodextrin + Flavoring
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AG1 - Nutritional Supplement
2023
N/A
~30

Find a Location

Who is running the clinical trial?

Athletic Greens InternationalLead Sponsor
4 Previous Clinical Trials
186 Total Patients Enrolled
3 Trials studying Gastrointestinal Microbiome
170 Patients Enrolled for Gastrointestinal Microbiome
~27 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top